# Correction: Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity

**Authors:** Romain Larrue, Sandy Fellah, Benjamin Hennart, Naoual Sabaouni, Nihad Boukrout, Cynthia Van der Hauwaert, Clément Delage, Meyling Cheok, Michaël Perrais, Christelle Cauffiez, Delphine Allorge, Nicolas Pottier

PMC · DOI: 10.1038/s41397-025-00381-2 · The Pharmacogenomics Journal · 2025-07-15

## Full-text entities

- **Diseases:** toxicity (MESH:D064420), DPYD (MESH:D054067)
- **Chemicals:** fluoropyrimidine (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12263416/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12263416/full.md

---
Source: https://tomesphere.com/paper/PMC12263416